Heartbeam Inc

NASDAQ BEAT

Data sourced from iex and EODHD
Download Data

Heartbeam Inc Enterprise Value to EBITDA (EV/EBITDA) on June 03, 2024

Heartbeam Inc Enterprise Value to EBITDA (EV/EBITDA) is NA on June 03, 2024, a NA change year over year. The EV/EBITDA ratio compares a company's enterprise value to its EBITDA. It provides insight into the company's valuation relative to its earnings and is commonly used in comparing the relative value of different companies within an industry. A lower ratio suggests a potentially more favorable valuation.
  • Heartbeam Inc 52-week high Enterprise Value to EBITDA (EV/EBITDA) is NA on June 03, 2024, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Heartbeam Inc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is NA on June 03, 2024, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Heartbeam Inc average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is NA.
NASDAQ: BEAT

Heartbeam Inc

CEO Mr. Richard M. Ferrari
IPO Date Nov. 11, 2021
Location United States
Headquarters 2118 Walsh Avenue, Santa Clara, CA, United States, 95050
Employees 15
Sector Healthcare
Industry Health information services
Description

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

StockViz Staff

September 8, 2024

Any question? Send us an email